Lapatinib in combination with capecitabine plus oxaliplatin (CapeOx) in HER2-positive advanced or metastatic gastric, esophageal, or gastroesophageal adenocarcinoma (AC): The TRIO-013/LOGiC Trial.
J. Randolph Hecht
Research Funding - GlaxoSmithKline
Yung-Jue Bang
Consultant or Advisory Role - GlaxoSmithKline
Honoraria - GlaxoSmithKline
Research Funding - GlaxoSmithKline
Shukui Qin
No relevant relationships to disclose
Hyun-Chul Chung
No relevant relationships to disclose
Jian-Ming Xu
No relevant relationships to disclose
Joon Oh Park
No relevant relationships to disclose
Krzysztof Jeziorski
No relevant relationships to disclose
Yaroslav Shparyk
Research Funding - GlaxoSmithKline
Paulo M. Hoff
Consultant or Advisory Role - GlaxoSmithKline
Research Funding - GlaxoSmithKline
Alberto F. Sobrero
Honoraria - Bayer; Roche; Sanofi
Pamela Salman
No relevant relationships to disclose
Jin Li
No relevant relationships to disclose
Svetlana Protsenko
No relevant relationships to disclose
Marc E. Buyse
Employment or Leadership Position - IDDI
Stock Ownership - IDDI
Karen Afenjar
No relevant relationships to disclose
Tomomi Kaneko
Employment or Leadership Position - GlaxoSmithKline
Stock Ownership - GlaxoSmithKline
Allison Kemner
Employment or Leadership Position - GlaxoSmithKline
Stock Ownership - GlaxoSmithKline
Sergio Santillana
Employment or Leadership Position - GlaxoSmithKline
Stock Ownership - GlaxoSmithKline
Michael F. Press
Consultant or Advisory Role - Genentech; GlaxoSmithKline; Halozyme Therapeutics ; NanoString Technologies; Roche; Ventana Medical Systems
Honoraria - Genentech; GlaxoSmithKline; Halozyme Therapeutics ; NanoString Technologies; Roche; Ventana Medical Systems
Research Funding - Roche/Genentech
Dennis J. Slamon
Consultant or Advisory Role - Novartis; Sanofi
Stock Ownership - Amgen; Pfizer